Pharmaceutical Supply Chain Security Act

The Pharmaceutical Supply Chain Security Act, also known as Bill 118 s 2454, is a piece of legislation introduced in the US Congress that aims to enhance the security of the pharmaceutical supply chain in the United States. The bill seeks to prevent the distribution of counterfeit or adulterated drugs by implementing a system for tracking and tracing prescription drugs as they move through the supply chain.

Under the provisions of the Pharmaceutical Supply Chain Security Act, drug manufacturers, wholesalers, and pharmacies would be required to implement systems for tracking and tracing prescription drugs at the individual package level. This would involve assigning a unique serial number to each package of prescription drugs and recording information about the drug's origin, destination, and handling as it moves through the supply chain.

The bill also includes provisions for verifying the authenticity of prescription drugs and detecting and responding to potential security threats in the supply chain. It would require drug manufacturers to report any suspected counterfeit or adulterated drugs to the Food and Drug Administration (FDA) and to take appropriate action to address the issue. Overall, the Pharmaceutical Supply Chain Security Act aims to improve the safety and security of the pharmaceutical supply chain in the United States by implementing a system for tracking and tracing prescription drugs and preventing the distribution of counterfeit or adulterated drugs.